Navigation Links
FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
Date:9/22/2007

king statements, including statements about the regulatory plans and timing for, and the expansion of, the Campath product label into earlier-line CLL, high-risk CLL, and combination and consolidation therapy. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected in these forward-looking statements. These risks and uncertainties include, among others: the actual efficacy and safety of Campath in these indications; the actual timing and content of submissions to and decisions made by the U.S. Food and Drug Administration and other regulatory authorities, and the other risks and uncertainties described in reports filed by Genzyme with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended, including without limitation the information under the heading "Risk Factors" in the Management's Discussion and Analysis of Financial Condition and Results of Operations section of the Genzyme Quarterly Report on Form 10-Q for the quarter ending June 30, 2007. Genzyme cautions investors not to place substantial reliance on the forward-looking statements contained in this press release. These statements speak only as of the date of this press release, and Genzyme undertakes no obligation to update or revise the statements.

This news release contains forward-looking statements based on current assumptions and forecasts made by Bayer Group management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in our annual and interim reports to the Frankfurt Stock Exchange and in our reports filed with the U.S. Securities and Exchange Commission (including our Form 20-F). The company assumes no liability whatsoever to update these forward-looking statements or to
'/>"/>

SOURCE Genzyme Corp. and Bayer HealthCare Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. FDA approves Phase 0 trial which tests experimental drugs on humans
2. FDA Approves Contraceptive Ring
3. FDA approves new device to treat womens bleeding disorder
4. FDA Approves New HIV Drug, Viread
5. FDA Approves Birth Control Skin Patch
6. FDA approves surgical gel
7. FDA Approves New Arthritis Drug, Bextra
8. FDA Approves Elidel Cream for Eczema
9. FDA approves drug for rare liver disease
10. FDA approves first pocket-sized EKG machine
11. FDA Approves New Anti-Clotting Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... Today, Steve Weatherford, current New York Giants ... announced the donation of their brains to science during ... Month. In an effort to raise awareness for the ... health, Rice and Weatherford spoke of their experiences on ... brain health a priority to avoid the consequences of ...
(Date:3/3/2015)... Man, Woman & Student of the Year engages ... ensure access to treatments for blood cancer patients, and ... families. Through this annual national ten-week campaign, individuals can ... world without blood cancers. The national titles will be ... be announced this summer. To date, these dedicated leaders ...
(Date:3/3/2015)... 2015 Dan E. Chambers, an experienced ... on capital crimes, recently spoke on the radio to give ... hosts of the Independent Journal Review radio show “The Right ... as a prosecutor and now as a criminal defense attorney ... in the trial and sentencing of this high-profile case. , ...
(Date:3/3/2015)... March 03, 2015 Today the Brain ... maker of bike, skate, snow, water, and motorcycle helmets, ... brain injury. The partnership kicks off with Nutcase donating ... http://www.nutcasehelmets.com to BIAA during the month of ... Each year BIAA leads the nation in observing Brain ...
(Date:3/3/2015)... London, UK (PRWEB) March 03, 2015 ... considerable growth of the augmentation market. The wearable augmentation ... in terms of size in the upcoming years. ... augmentation market owing to a big number of new ... the North American region, high technological advancements as well ...
Breaking Medicine News(10 mins):Health News:Steve Weatherford and Sidney Rice Reveal Donation for Brain Injury Awareness Month 2Health News:The Leukemia & Lymphoma Society’s Oregon and SW Washington Chapter Kicks Off Their Eleventh Annual Man, Woman & Student of the Year Campaign 2Health News:The Leukemia & Lymphoma Society’s Oregon and SW Washington Chapter Kicks Off Their Eleventh Annual Man, Woman & Student of the Year Campaign 3Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 2Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 3Health News:Brain Injury Association of America Partners with Nutcase Helmets to Raise Awareness About Brain Injury 2Health News:Human Augmentation Market to Pose 43.5% CAGR Through 2020, States MarketsandMarkets in its New Research Study Now Available at MarketPublishers.com 2
... to profoundly impact prediction ... and treatment of genetic diseases., REDMOND, Wash., ... prevent adverse drug responses,within prescription medicine, and provide greater insight ... Alzheimer,s,disease, are just two of six research projects Microsoft Research ...
... April 17 Seven children,from across the United ... nerve rerouting surgery for patients,with spina bifida. The ... Royal Oak, Mich., The children previously required ... or endured significant incontinence. But as a result ...
... anemia, other diseases that affect red blood cells , , THURSDAY, ... their skin, says a new study that showed the skin ... environment and in stimulating kidney production of the hormone erythropoietin ... red blood cells that carry and deliver oxygen throughout the ...
... 2008 The new Centers for Medicare & ... reduce payments for three hospital-acquired infections (HAIs) will ... healthcare executives and professionals sponsored by the Association ... Mastering the New CMS Regulation: Implications for Infection ...
... at National Jewish Medical and Research Center are conducting ... to food. They are feeding peanut- and egg-allergic people ... foods to see if they can induce the participants ... hope these trials will lead to the development of ...
... Investment Trust Inc.,(NYSE: CRE ) today announced it ... to Care,s Board of Directors, which increases the,number of ... capacity as President of Corporate Finance at CIT, Owens, ... unit leaders,in assessing their go-to-market models, developing integrated distribution,platforms ...
Cached Medicine News:Health News:Scientists Explore Human Gene Pool With Help From Microsoft Research 2Health News:Scientists Explore Human Gene Pool With Help From Microsoft Research 3Health News:Scientists Explore Human Gene Pool With Help From Microsoft Research 4Health News:Scientists Explore Human Gene Pool With Help From Microsoft Research 5Health News:Beaumont Sees Results in Nation's 1st Urinary Nerve Rewiring Surgeries for Spina Bifida Patients 2Health News:Beaumont Sees Results in Nation's 1st Urinary Nerve Rewiring Surgeries for Spina Bifida Patients 3Health News:Mice Can Sense Oxygen Through Their Skin 2Health News:APIC Conference to address new CMS regulations 2Health News:Researchers evaluating food allergy treatment 2Health News:Care Investment Trust Names Walter J. Owens to Board of Directors 2
(Date:3/3/2015)... -- Registration is officially open for MEDTEC China South 2015, ... Shenzhen Convention & Exhibition Center. The Shenzhen ... the MEDTEC China family of events. MEDTEC China South, an ... serve the South China market through ... region for China,s medical device industry. ...
(Date:3/3/2015)... 3, 2015  RedHill Biopharma Ltd. (NASDAQ/TASE: ... biopharmaceutical company primarily focused on late clinical-stage, ... diseases, including gastrointestinal cancers, today announced that ... Officer, will be presenting at VirtualInvestorConferences.com, a ... March 5, 2015, at 10:00 am EST. ...
(Date:3/3/2015)... - CPhI and P-MEC China 2015 ... China - The 15th CPhI China, ... Shanghai New International Expo Center, on 24th June, 2015. ... was introduced to China in 2001. It has successfully developed ... global pharmaceutical industry over the past 15 years. With continuously ...
Breaking Medicine Technology:Pre-registration Open for 2015 MEDTEC China South 2Pre-registration Open for 2015 MEDTEC China South 3RedHill Biopharma to Present at VirtualInvestorConferences.com Online Event on March 5, 2015 2RedHill Biopharma to Present at VirtualInvestorConferences.com Online Event on March 5, 2015 3RedHill Biopharma to Present at VirtualInvestorConferences.com Online Event on March 5, 2015 415th Anniversary, Be Part of Chinese Pharma Dream 215th Anniversary, Be Part of Chinese Pharma Dream 3
... 1, 2011 Allscripts (NASDAQ: ... Physicians , one of the largest independent physician associations (IPA) ... by dbMotion to deliver end-to-end information connectivity for ... (Logo: http://photos.prnewswire.com/prnh/20100901/CG58147LOGO ) The Allscripts ...
... HOFFMAN ESTATES, Ill., Nov. 1, 2011 Life Spine, ... markets products for the surgical treatment of spinal disorders, ... patents from its cadre of 80 plus filings. ... of three of the six new product lines launching ...
Cached Medicine Technology:Brown & Toland Physicians Selects Allscripts Community Record to Connect 1,500 Bay Area Physicians 2Brown & Toland Physicians Selects Allscripts Community Record to Connect 1,500 Bay Area Physicians 3Brown & Toland Physicians Selects Allscripts Community Record to Connect 1,500 Bay Area Physicians 4Brown & Toland Physicians Selects Allscripts Community Record to Connect 1,500 Bay Area Physicians 5
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: